5% stakes
Ra Capital Management
Institution
- 5% stake reports
- 143
- 5% stake stocks
- 79
- Latest report
- 26/09/30
5% stake reports
| Stock | ||
|---|---|---|
| Corbus Pharmaceuticals Holdings CRBP09/30 | 9.9%1,914,788 sh | First report |
| BetterLife Pharma BETRF09/22 | 9%55,420,000 sh | First report |
| Sionna Therapeutics SION09/21 | 14.3%6,476,193 sh | −8.3pp |
| Tyra Biosciences TYRA09/17 | 19.9%14,130,492 sh | −1.3pp |
| Jatt III Acquisition JTTT09/03 | 5.1%450,000 sh | First report |
| Latigo Biotherapeutics LTGO08/17 | 8.4%5,295,690 sh | First report |
| GH Research GHRS08/14 | 7.1%4,897,182 sh | −5.3pp |
| Septerna SEPN08/14 | 11.8%5,525,324 sh | No earlier report |
| Fulcrum Therapeutics FULC08/14 | 0%0 sh | −9.9pp |
| Edgewise Therapeutics EWTX08/14 | 7.8%8,392,730 sh | −2.1pp |
| CervoMed CRVO08/14 | 8.6%1,266,143 sh | −1.3pp |
| Biocryst Pharmaceuticals BCRX08/14 | 6.2%15,827,186 sh | −1.1pp |
| Avalo Therapeutics AVTX08/14 | 6.3%3,483,099 sh | −3.6pp |
| Atrium Therapeutics RNA08/14 | 0%0 sh | −5.6pp |
| Adicet Bio ACET08/14 | 9.9%935,486 sh | −2.4pp |
| Aclaris Therapeutics ACRS08/14 | 9.1%12,723,026 sh | +2.8pp |
| TCGX Acquisition TCGX08/13 | 5.5%500,000 sh | First report |
| Wave Life Sciences WVE08/11 | 16.8%34,314,406 sh | −0.3pp |
| SAB Biotherapeutics SABS08/10 | 9.9%9,609,852 sh | +0.0pp |
| Obsidian Therapeutics OBX08/10 | 9.7%5,957,103 sh | First report |
